14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.86 $1.27 Friday, 3rd May 2024 BLUE stock ended at $0.90. This is 0.387% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.11% from a day low at $0.89 to a day high of $0.94.
90 days $0.86 $1.92
52 weeks $0.86 $5.53

Historical bluebird bio prices

Date Open High Low Close Volume
Feb 26, 2021 $28.24 $31.14 $27.43 $31.10 5 864 130
Feb 25, 2021 $25.93 $28.35 $25.60 $28.12 8 267 038
Feb 24, 2021 $26.30 $26.69 $25.62 $25.92 3 496 544
Feb 23, 2021 $25.94 $26.45 $24.24 $25.62 4 420 606
Feb 22, 2021 $26.72 $27.09 $26.01 $26.07 2 529 160
Feb 19, 2021 $27.30 $27.32 $26.57 $26.68 4 472 832
Feb 18, 2021 $28.10 $28.23 $26.85 $26.95 4 457 516
Feb 17, 2021 $28.59 $29.95 $27.72 $28.02 6 816 649
Feb 16, 2021 $33.50 $34.36 $26.11 $28.44 18 060 327
Feb 12, 2021 $45.52 $46.45 $44.65 $45.76 771 677
Feb 11, 2021 $46.75 $47.09 $44.66 $45.77 794 048
Feb 10, 2021 $46.81 $47.19 $45.52 $46.52 741 959
Feb 09, 2021 $48.11 $48.43 $46.40 $46.54 750 417
Feb 08, 2021 $48.11 $48.92 $47.30 $47.89 1 017 420
Feb 05, 2021 $47.41 $47.88 $47.03 $47.70 958 495
Feb 04, 2021 $46.73 $47.42 $45.91 $47.28 842 315
Feb 03, 2021 $46.74 $47.86 $46.42 $46.45 782 886
Feb 02, 2021 $46.00 $46.90 $45.35 $46.41 1 367 109
Feb 01, 2021 $45.41 $45.95 $44.20 $45.74 917 678
Jan 29, 2021 $44.74 $46.29 $43.89 $44.55 1 217 547
Jan 28, 2021 $47.24 $47.50 $44.81 $45.00 1 224 876
Jan 27, 2021 $45.22 $46.98 $44.66 $46.77 2 251 007
Jan 26, 2021 $48.25 $48.40 $45.60 $46.07 1 125 179
Jan 25, 2021 $48.12 $48.20 $46.17 $48.10 1 562 089
Jan 22, 2021 $46.01 $46.91 $46.01 $46.64 1 263 561
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT